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Loss of podocytes by apoptosis characterizes the early stages
of diabetic nephropathy. To examine its mechanism we
studied glomeruli and podocytes isolated from db/db mice
with early diabetic nephropathy and albuminuria.
Phosphorylation of AKT (protein kinase B, a key survival
protein) was found to be lower in the glomeruli of 12 week
old db/db compared to db/þ mice. In vitro, insulin
phosphorylated AKT solely in podocytes from db/þ mice.
Serum deprivation and exposure to tumor necrosis factor-a
significantly compromised cell viability in podocytes from db/
db but not from db/þ mice, and this was associated with a
significant decrease in AKT phosphorylation. Inhibition of
AKT was necessary to achieve the same degree of cell death
in db/þ podocytes. Our study shows that podocyte inability
to respond to insulin and susceptibility to cell death may
partially account for the decreased podocyte number seen in
early diabetic nephropathy.
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The pathogenesis of proteinuria in diabetic nephropathy
(DN) is not readily explained by the associated mesangial
matrix expansion and glomerular basement membrane
thickening. Recently, the role of podocytes in DN has
become the subject of intense translational research effort.1,2
Podocyte foot process effacement and decreased podocyte
number has been reported in both patients with type 1 and
type 2 diabetes.3–8 Studies on kidney biopsies from patients
with type2 diabetes showed that loss of podocytes in DN
predicts the progressive course of the disease and is a critical
determinant for the development of albuminuria.9 Decreased
podocyte density7 as well as podocyte detachment10 occurs in
the early stages of DN in humans, and correlates with A1C
and systolic blood pressure.8 A similar loss of podocyte
number has been described in experimental models of DN
such as the db/db mouse.11 This occurs at an age when
microalbuminuria is observed without any significant blood
pressure increase.12
Among several signaling pathways that are functional in
podocytes, protein kinase B/AKT activation has been
recognized as a key survival factor for podocytes exposed
to oxidized low-density lipoproteins.13 Similarly, darbapoie-
tin protects podocytes from ultraviolet-C irradiation induced
apoptosis via regulation of AKT.14 Thus, podocyte loss in
early DN may occur through an inability to phosphorylate
AKT in response to physiological stimuli, such as insulin.
We hypothesize that podocyte inability to regulate AKT
precedes the onset of significant albuminuria in db/db mice
and is responsible for their susceptibility to cell death. We
showed that AKT phosphorylation is downregulated in
glomeruli from 12-week-old db/db mice when compared
with db/þ mice. We cultured and characterized podocytes
from db/db and db/þ mice of the same age, and found that
db/db podocytes are more susceptible to cell death induced
by serum deprivation and tumor necrosis factor-a (TNF-a)
exposure. AKT phosphorylation was markedly suppressed
by stress stimuli in db/db podocytes when compared to
db/þ . The addition of an AKT inhibitor in db/þ podocytes
lead to comparable degree of cell death to the one observed
in db/db podocytes, suggesting a role for AKT in this
model of DN.
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RESULTS
Onset of significant albuminuria occurs at 12 weeks of age in
db/db mice on a C57BL6 background
Glycemia, body weight, and albumin-to-creatinine ratios
were evaluated every 1–3 weeks in six db/db and six db/þ
mice from 8 to 19 weeks of age. While glycemia and body
weight were already significantly different at 8 weeks of age
(Table 1), a significant difference in albumin-to-creatinine
ratio was observed only at 12 weeks of age and persisted
thereafter. In a second experiment db/þ and db/db mice
were sacrificed at 12 weeks of age and kidneys were obtained
for histology and microdissection of glomeruli for protein
analysis and for podocytes culture. No difference in
mesangial expansion was observed at this early stage of the
disease when compared to controls (0.4±0.2 vs 0.5±0.4;
Figure 1).
Glomerular AKT phosphorylation is downregulated in
12-week-old db/db mice
Phosphorylated and total AKT were analyzed on micro-
dissected glomeruli by Luminex technology. db/db glomeruli
were characterized by decreased phosphorylated AKT/total
AKT when compared with db/þ (Figure 2a). The same assay
was performed on whole cortices, where no difference in
phosphorylated AKT/total AKT was observed (Figure 2b).
We then performed immunofluorescence staining for phos-
phorylated AKT and synaptopodin in db/þ kidney sections,
and found that they partially colocalized (Figure 2c).
Immortalized podocytes from db/db mice and db/þ mice
retain a podocyte-specific phenotype
Initial outgrowth of podocytes from microdissected glomer-
uli was immortalized as described in methods. We specifically
decided not to use the SV40 large T-antigen construct for
transfection experiments, since large T-antigen expression
interferes with insulin signaling in other cell types.15–17
Podocytes remained in a proliferative state, but were positive
for nephrin by western blotting and immunofluorescence
(Figure 3a and b). Western blot analysis also confirmed
weak positivity for synaptopodin, although synaptopodin
detection was possible only when 70 mg of total protein
were analyzed (Figure 3b). In addition, nephrin and WT-1
expressions were confirmed by standard reverse transcriptase-
polymerase chain reaction (Figure 3c).
Podocytes from 12-week-old mice are unable to phosphor-
ylate AKT in response to insulin
When podocytes were cultured in regular media, no baseline
difference in phosphorylated AKT/total AKT was observed.
However, when exposed to increasing concentration of
insulin, db/þ podocytes had a dose-dependent increase in
phosphorylated AKT/total AKT, whereas db/db podocytes
showed no response at insulin concentrations between 0.3
and 30 nM (Figure 4a). This impaired ability of insulin
to phosphorylate AKT was most likely mediated by the
insulin receptor, since insulin-like growth factor-1 (IGF-1)
(100 ng ml1) resulted in AKT phosphorylation in both
Table 1 |Metabolic parameters in db/+ and db/db mice between 9 and 19 weeks of age
8 weeks 10 weeks 12 weeks 16 weeks 19 weeks
Weight (g)
db/+ 18.98±0.5 20.28±0.6 19.84±1.8 21.72±1.1 21.98±0.4
db/db 34.02±0.6* 39.44±0.18* 46.22±0.4* 51.2±1.8** 53.66±1.6**
Fasting blood glucose (mg per 100ml)
db/+ 124.5±5.07 137.6±10 148.8±16.4 98.8±11 97.2±6.2
db/db 318.7±26.8* 207±13* 302±18.7* 260±29.4** 406±67.8**
Albumin/creatinine (lgmg1)
db/+ 17.20±1.74 11.33±12.10 16.02±7.41 16.3±27 16.5±2
db/db 14.80±3.652 44.51±38.37 67.12±16.6* 120±50* 140±40*
Weight in grams, fasting blood glucose concentrations (mg per 100ml) and urinary albumin-to-creatinine ratio on a spot morning urine collection (mgmg1) are reported. Six
db/+ and six db/db at different weeks of age (8, 10, 12, 16, 19) were studied. Mean, standard deviations, and significant differences between db/+ and db/db at each time
point are shown; *Po0.05, **Po0.01.
db/+ db/db
20×
63×
Figure 1 |Histology of kidney cortex of 12-week-old db/þ
and db/db mice. Shown are representative periodic acid–
Shiff-stained 5-mm sections of db/þ and db/db kidney cortex at
original magnifications of  20 and  63. No difference in the
degree of mesangial expansion could be detected by
semiquantitative analysis.
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db/þ and db/db podocytes (data not shown). In fact, both
phosphorylated and total IGF-1 receptor and insulin receptor
substrate (IRS)-1 did not differ between diabetic and
non-diabetic podocytes (P¼NS, data not shown). Because
the phosphatase and tensin homolog deleted on chromosome
10 (PTEN) has been shown to suppress insulin signaling
through AKT,18 we investigated phosphorylated PTEN/total
PTEN in our model. PTEN was not affected by increasing
insulin concentration in either db/þ or db/db podocytes
(Figure 4b). However, db/db podocytes were characterized by
decreased phosphorylation of the insulin receptor b-subunit
(IR) both at baseline and after insulin exposure (Figure 4c).
No difference in total IR was observed between diabetic and
non-diabetic podocytes. We defined such inability of insulin
to activate downstream signaling events as cellular insulin
resistance.
db/db podocytes are less viable than db/þ podocytes
Since AKT has been described as an important survival
factor, we tested whether db/db podocytes are
more susceptible to cell death than db/þ podocytes. We
found that serum starvation and addition of TNF-a
(2000 U ml1) to the culture media resulted in a
much higher rate of cell death in db/db podocytes
when compared to db/þ (Figure 5). When comparing
treated and untreated podocytes, serum starvation induced
significant increase in cell death in db/db podocytes
(P¼ 0.029), but not in db/þ podocytes (P¼ 0.101). The
observed cell death was not mediated by activation of
caspases, since flow cytometric analysis of fluorescein
isothiocyanate (FITC)-conjugated zVAD-labeled cells was
not different between cells and between stimuli (data not
shown).
AKT is responsible for the different viability of db/db and
db/þ podocytes
To assess the role of AKT as a key factor responsible for the
observed difference in the susceptibility to cell death, we
tested the ratio of phosphorylated to total AKT in cells
exposed to either 0.1% fetal bovine serum (FBS) or 0.1%
FBSþTNF-a (2000 U ml1). We found that such stimuli lead
to profound downregulation of AKT in db/db podocytes, but
not in db/þ podocytes (Figure 6a). Interestingly, addition of
an AKT inhibitor to db/þ podocytes resulted in cell death
rate resembling the one of db/db podocytes exposed to 0.1%
FBSþTNF-a (Figure 6b). Addition of an AKT inhibitor to
db/db podocytes exposed to 0.1% FBSþTNF-a did not
result in further worsening of cell death. Both p-38 (Figure
7a) and IkB (Figure 7b) were markedly activated by TNF-a,
but not by serum starvation, to a degree that did not
differ between db/db and db/þ podocytes, suggesting that
12
Synaptopodin Phospho AKT Combined
8
7
6
5
4
3
2
1
0
Ph
os
ph
o/
to
ta
l A
KT
Ph
os
ph
o/
to
ta
l A
KT10
8
6
4
2
0
db/+
P -value
P -value 0.9306
0.0257
∗
db/db db/+ db/db
Figure 2 |Phosphorylated AKT is decreased in glomeruli from db/db mice when compared with db/þ . (a) Bar graph representation
of the ratio between phosphorylated and total AKT measured in isolated glomeruli. *Po0.05. (b) Bar graph representation of the ratio
between phosphorylated and total AKT measured in whole-kidney cortex. (c) Immunofluorescence staining for synaptopodin and
phosphorylated AKT in db/þ kidney cortex showed partial colocalization.
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Figure 3 |Characterization of db/þ and db/db podocytes.
(a) Representative immunofluorescence staining for nephrin in
db/þ podocytes. db/db podocytes had a very similar pattern of
staining. Both cytoplasmic and membrane localization of nephrin
was observed. (b) Representative western blot analysis of
db/þ (1) and db/db (2) podocytes for nephrin and
synaptopodyn. (c) Standard reverse transcriptase-polymerase
chain reaction for nephrin, WT-1, and actin is shown.
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neither p-38 nor nuclear factor-kB (NF-kB) pathway
were responsible for the observed difference in podocytes
susceptibility to cell death.
DISCUSSION
Podocytopenia has become one of the hallmarks of early
DN.3–10 Although mechanisms leading to podocytopenia are
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Figure 4 | Insulin phosphorylates AKT in db/þ but not in db/db podocytes. db/db and db/þ podocytes were exposed to increasing
concentration of insulin (from 0.3 to 30 nM) for 24 h. Lysates were analyzed for phosphorylated AKT/total AKT (a) and for phosphorylated
PTEN/total PTEN (b), and data were expressed as percentage of untreated cells; *Po0.05, ***Po0.001. (c) Phosphorylated IR was evaluated
quantitatively in db/þ and db/db podocytes at baseline and found to be threefold higher in db/þ podocytes when compared with db/db
controls. Data are expressed as U mg1 of protein in order to be able to appreciate the baseline difference among db/þ and db/db;
#Po0.05. Insulin stimulates IR phosphorylation in db/þ but not in db/db podocytes; *Po0.05.
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Figure 5 |db/db podocytes are more susceptible to cell death than db/þ podocytes. The percentage of 7-amino-actinomycin-
D-positive cells was analyzed by flow cytometry in untreated cells (left), cells exposed to 0.1%FBS (center), and in cells exposed to
0.1%FBSþ TNF-a (right). Shown above are bar graph representations of 3–4 different experiments and below a representative bright-field
image (original magnification  10) of db/þ and db/db podocytes exposed to the different stimuli; *Po0.05.
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not entirely characterized, a role for AKT as a survival signal
in podocytes has been described. AKT/PKB is usually
phosphorylated in response to insulin, and podocytes are a
novel target for insulin and can regulate glucose uptake upon
insulin stimulation.19 Interestingly, insulin-receptor signaling
is highly compromised in the retina of a model of
streptozotocin-induced diabetes in rats,20 suggesting that a
disrupted insulin-signaling pathway may be responsible for
the development of microvascular complications of diabetes.
In the kidney, studies on patients with type2 diabetes have
suggested that insulin resistance per se is independently
associated with microalbuminuria.21 With this study, we were
able to demonstrate that insulin-dependent phosphorylation
of AKT is impaired in murine podocytes isolated from mice
with diabetes at the onset of albuminuria, and that such
dysregulation of AKT phosphorylation is associated with
podocytes’ susceptibility to cell death.
We elected to use the db/db mouse model on a C57BL6
background because it is characterized by pancreatic islets
cells hypertrophy rather than islet cell degeneration as seen in
the C57BLKS/J background.22 In addition, since we wanted
to study the early phases of DN, use of the C57BLKS/J
background would have been unpractical, since albuminuria
is already present at 6 weeks of age.22,23 Based on our findings
that albuminuria develops at 12 weeks of age on the C57BL6
background (Table 1), prior to significant mesangial expan-
sion (Figure 1), we chose this age for the subsequent analysis
of glomeruli and podocyte culture.
AKT is a key survival signal in podocytes in the
experimental model of darbapoietin cytoprotection and
oxidized low-density lipoprotein toxicity.13,14 On the con-
trary, increased podocyte apoptosis despite AKT activation
has also been reported,11 and vascular endothelial growth
factor activates AKT in nephrin-deficient podocytes, without
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Figure 6 |AKT plays a role in db/db podocytes susceptibility to cell death. (a) Bar graph representation of four independent
experiments showing AKT phosphorylation in db/þ and db/db podocytes exposed to 0.1%FBS and 0.1%FBSþ TNF-a. Data are expressed
as percentage of phosphorylated/total AKT when compared with untreated cells (controls). 0.1%FBS and 0.1%FBSþ TNF-a induced
profound downregulation of AKT in db/db podocytes. A similar but not significant trend was observed in db/þ podocytes. (b) db/þ and
db/db podocytes were treated with an AKT inhibitor in addition to 0.1%FBSþ TNF-a and cell death quantified by 7-amino-actinomycin-D
staining. AKT inhibition in db/þ cells lead to threefold increase in cell death, similar to what was observed in db/db exposed to
0.1%FBSþ TNF-a; ***Po0.001, *Po0.05.
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Figure 7 | TNF-a similarly activates p-38 and IkB in db/db and db/þ podocytes. Bar graph representations of four independent
experiments showing the effect of 0.1%FBS and 0.1%FBSþ TNF-a to p-38 phosphorylation (a) and IkB phosphorylation (b) in db/þ and db/
db cells. 0.1% FBS did not affect p-38 and IkB activity alone, whereas addition of TNF-a stimulated both p-38 and IkB equally in both cell
types. Data are expressed as percentage of phosphorylated/total p-38 and IkB when compared with the control (untreated) cells;
***Po0.001, **Po0.01, *Po0.05.
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rescuing them from apoptosis.24 More recently, AKT has
been reported to mediate proximal tubular cells hypertrophy,
which is usually observed in the early phases of DN.25
Activation of AKT was also described in the kidney of db/db
mice in the early phases of DN; of note, whole cortices and
not glomeruli were used.26 Our data show that glomeruli
from 12-week-old db/db mice are characterized by less
phosphorylated AKT when compared with db/þ glomeruli,
suggesting that loss of AKT activity may be a very early
contributor to podocyte damage resulting in albuminuria
(Figure 2a). Although leptin regulates insulin sensitivity per
se,27,28 our result showing equal degree of AKT phosphoryla-
tion in whole-kidney cortices of db/db and db/þ mice
(Figure 2b) suggests that leptin-receptor mutation per se is
not responsible for AKT phosphorylation in our model. Since
AKT phosphorylation may be important to maintain normal
podocyte physiology, we cultured db/þ and db/db podo-
cytes to address this question.
We have previously shown that glomerular cells in culture
retain their in vivo phenotype when isolated from mice with
diabetic nephropathy and/or glomerulosclerosis.29,30 HPV16-
transformed podocytes were used because our preliminary
experiments showed an equal ability of insulin to phosphor-
ylate AKT in HPV16-transformed and untransformed
podocytes (data not shown). Although podocytes cultured
as described retain a proliferative phenotype, we were able to
detect podocyte-specific markers, confirming that the
phenotype was at least partially retained (Figure 3). Among
the markers tested, nephrin expression was similar between
db/þ and db/db podocytes (Figure 3). This is particularly
important, since nephrin has been recently shown to mediate
insulin sensitivity in podocytes.31
Although there was a difference in phosphorylated AKT
content in db/þ versus db/db glomeruli, db/þ and db/db
podocytes exhibited the same level of phosphorylated AKT
under standard cell culture conditions. However, insulin
stimulated AKT phosphorylation in a dose-dependent
manner in db/þ but not in db/db podocytes via a PTEN-
independent mechanism (Figure 4a and b), supporting the
hypothesis that the insulin-signaling pathway may play an
important role in podocyte pathophysiology in diabetes.
Although high glucose concentrations failed to have any
effect on AKT phosphorylation in murine podocytes,11 it is
important to note that the latter experiments were performed
to study the effect of acute exposure to high glucose
concentration (18 h) rather than the specific response to
insulin in diabetic podocytes cultured after chronic exposure
to a diabetic environment in vivo. Interestingly, preliminary
results showed that the ability of IGF-1 to phosphorylate
AKT was comparable in both db/db and db/þ podocytes,
suggesting that a specific defect in insulin response occurred
in diabetic podocytes. Furthermore, a lower ability to
phosphorylate the insulin receptor (Figure 4c), but not the
IGF-1 receptor or IRS-1, was observed in db/db podocytes
compared with db/þ . This was unexpected, since increased
serine phosphorylation of IRS-1 is described in the peripheral
tissue of diabetic patients and experimental models of type2
diabetes.32,33 More recently, however, a role for inflammatory
mediator in the suppression of the insulin pathway at the
level of receptor phosphorylation was described in patients
with insulin resistance,34 suggesting that modulation of the
insulin pathway at sites different than IRS-1 may occur in
diabetes. Our findings from db/db podocytes are rather
different than those observed in mesangial cells from db/db
mice, where we have reported an autocrine activation of the
IGF-1 pathway.35 Such cell-specific modulation of insulin
and IGF-1 pathway in different glomerular cells is interesting
and further studies are needed to elucidate the underlying
mechanisms.
We then choose to look at cell death as a biological read
out linked to AKT phosphorylation. We observed that db/db
podocytes were by far more susceptible to cell death than db/
þ podocytes (Figure 5). We choose serum starvation and
exposure to TNF-a as stress stimuli, since serum starvation
has been linked to podocytes apoptosis in prior studies,36 and
TNF-a is strongly upregulated in the early phases of DN.37,38
Interestingly, this was associated with downregulation of
AKT phosphorylation in db/db but not db/þ podocytes
(Figure 6a). Addition of an AKT inhibitor to db/þ
podocytes exposed to 0.1% FBS and TNF-a was necessary
to observed a degree of cell death comparable to the one
observed in db/db podocytes (Figure 6b), suggesting that cell
survival in podocytes is AKT-dependent. Finally, since NF-kB
and p-38 are also important mediators of DN that are
relevant to cell survival,11,39,40 we tested whether a different
activation of such pathways occurred after exposure to serum
starvation and TNF-a. Serum starvation alone was able to
induce cell death in db/db podocytes (Figure 5), but did not
result in p-38 and IkB phosphorylation (Figure 7). In
addition, TNF-a induced phosphorylation of IkB and p-38 to
a similar degree in db/db and db/þ podocytes, suggesting
that NF-kB and p-38 pathways are not responsible for the
different susceptibility to cell death observed between
diabetic and non-diabetic cells. Since experiments were
performed with proliferating transformed podocytes in vitro,
caution needs to be taken when trying to apply our findings
to the in vivo setting. Nevertheless, our experiments
consistently suggest the importance of the integrity of the
insulin-signaling pathway in podocytes. We failed to detect
an increased apoptosis by FITC-labeled zVAD in those
diabetic podocytes undergoing cell death. However, evidence
of oxygen-species mediated DNA damage in podocytes has
been described even in the absence of significant apoptosis.41
In conclusion, we have shown that podocytes
from diabetic mice are already resistant to insulin at
the onset of significant albuminuria. This translates in
decrease ability to phosphorylate AKT in response
to physiologic stimuli and is associated with increased
susceptibility to cell death through an NF-kB- and
p-38-independent pathway. Thus, restoring insulin sensitivity
in podocytes from diabetic mice may prevent the
podocytopenia observed in the early phases of diabetic
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nephropathy, and may partially account for the podocyte-
protective properties of thiazolidinediones.42–44
MATERIALS AND METHODS
Mice killing and experimental design
Twelve B6.Cg-mþ /þ Leprdb/Leprdb (db/db) and 12 B6.Cg-m
þ /þ Leprdb/þ (db/þ ) female mice were purchased from Jackson
Laboratories (Bar Harbor, ME, USA). All animal procedures were
conducted under protocols approved by the Institutional Animal
Care and Use Committee. Measurements of body weight, fasting
blood glucose levels, and urinary albumin-to-creatinine ratio
(mg mg1) were performed weekly between week 8 and 19 in a first
set of mice (six per group). After characterization of the age at which
significant albuminuria develops, a second set of mice (six per
group) were killed at 12 weeks of age. Kidneys were perfused in situ
with 6 ml of phosphate-buffered saline. Left kidney upper pole was
collected and digested with a 5% collagenase type-IV solution
(Sigma, St Louis, MO) for 40 min at 37 1C. Glomerular micro-
dissection was performed at 4 1C in a buffered solution containing
protease inhibitors (Roche, Indianapolis, IN, USA) and phosphatase
inhibitors (Sigma). A total of 300–400 glomeruli per mouse were
collected in lysis buffer (Bio-Rad, Hercules, CA, USA). The lower
pole of right kidney cortical tissue was collected and homogenized in
lysis buffer using an electric homogenizer (PRO Scientific, Oxford,
CT, USA). After a brief cycle of sonication, protein concentration
was determined for both glomerular and cortical lysate samples with
a detergent-compatible protein assay (Bio-Rad). The remaining
right kidney portion was embedded in OCT and stored at 80 1C.
The right kidney was then perfused in situ with 4% paraformalde-
hyde, postfixed in the same solution for at least 12 h, and then
paraffin embedded.
Glycemia and albumin/creatinine ratio measurements
Fasting glucose levels were measured weekly from tail blood samples
using standard test strips and glucometer (Bayer, Pittsburgh, PA,
USA). Urine samples were collected weekly and at killing. Albumin
content was measured by enzyme-linked immunosorbent assay
(Bethyl Laboratories, Montgomery, TX, USA). Urinary creatinine
was assessed by an assay based on the Jaffe method (Stanbio, San
Antonio, TX, USA). Values are expressed as micrograms of albumin
per mg of creatinine.
Histology and immunofluorescence
Slide sections were prepared from the paraffin-embedded samples
collected as described above. Periodic acid–Shiff ’s staining of 5-mM
thick slides was performed and 20 glomeruli per section analyzed for
mesangial expansion by semiquantitative analysis (scale from 0 to 5)
by two blinded independent investigators. For immunofluorescence,
frozen sections were fixed in 4% paraformaldehyde for 10 min and
incubated overnight with 90% goat serum. Slides were washed in
phosphate-buffered saline solution with 0.1% Tween-20 (Sigma)
and then incubated for 30 min at room temperature with 10%
Accutase (Chemicon, Temecula, CA, USA) in goat serum. Slides
were incubated overnight at 4 1C with primary antibody against
synaptopodin (1:100; Biodesign International, Saco, ME, USA) and
phosphorylated AKT (1:200; Santa Cruz Biotechnology, Santa Cruz,
CA, USA). Final incubation with secondary antibodies Alexa 488
and 568 (Molecular Probes-Invitrogen, Carlsbad, CA, USA) was
performed for 1 h prior to mounting with a 40,6-diamidino-2-
phenylindole (DAPI)-containing Vectashield solution (Vector
Laboratories, Burlingame, CA, USA).
Podocyte culture and characterization
Podocyte isolation, culture, transformation, and characterization
were performed as follows: 15–30 glomeruli were microdissected
from 12-week-old mice and cultured for 48–72 h at 37 1C and 10%
CO2 in fibronectin-coated wells (BD Biosciences, San Jose, CA,
USA), in Dulbecco’s modified Eagle’s medium/F12 media with 10%
FBS (Gibco-Invitrogen, Carlsbad, CA, USA). Glomerular cells were
transfected and immortalized with a replication-deficient retrovirus
containing human papilloma virus 16 E6/E7 DNA containing a
gentamycin resistance cassette (gift from Dr Hong Yu). Preliminary
experiments comparing primary cultured podocytes and HPV16
transformed podocytes showed similar degree of AKT phosphoryla-
tion in response to insulin.
Once confluent, cells were trypsinized and exposed to ZO1-FITC
(Zymed, San Francisco, CA, USA) and separated using anti-FITC
microbeads (Miltenyi Biotec, Auburn, CA, USA). For cell char-
acterization, multi-chamber slides were plated, slides were fixed with
4% paraformaldehyde at 37 1C for 20 min, washed with phosphate-
buffered saline thrice, and then incubated with universal blocking
solution (BioGenex, San Ramon, CA, USA) for 60 min at room
temperature after a 10-min permeabilization step with 0.05% Triton
X-100. Cells were then incubated overnight at 4 1C with guinea pig
polyclonal anti-nephrin antibody (intracellular domain; Research
Diagnostic Inc., Concord, MA, USA). After three washes with
phosphate-buffered saline, incubation with the secondary antibody
(Alexa-488 goat anti-guinea pig IgG, 1:200 dilution; Invitrogen,
Carlsbad, CA, USA) for 60 min at room temperature was performed.
Irrelevant IgG isotype served as negative control. For western blots,
lysates were heated to 99 1C for 6 min and an equal amount of
protein loaded onto each well of sodium dodecyl sulfate-
polyacrylamide gel electrophoresis gel (Bio-Rad), separated by
electrophoresis, and transferred onto a nitrocellulose membrane
(Amersham Biosciences, Piscataway, NJ, USA). The membrane was
blocked in 5% non-fat milk (Carnation, Wilkes-Barre, PA, USA) in
tris-(hydroxymethyl)-aminomethane-buffered saline containing
0.1%Tween-20 for 1 h and then incubated with the anti-synapto-
podin antibody or with the anti-nephrin antibodies described above
at 4 1C overnight. Recombinant intracellular nephrin was used as
blocking peptide to confirm band specificity (data not shown). The
membrane was then washed and incubated with secondary antibody
(goat-anti-mouse or goat-anti-guinea-pig HRP-conjugated, 1:1000
dilution; Pierce, Rockford, IL, USA) for 60 min at room tempera-
ture, followed by enhanced chemiluminescence solution for bands
visualization. Lysates from COS-7 cells were used as negative
controls. Standard reverse transcriptase-polymerase chain reaction
analysis for WT-1, nephrin, and b-actin was performed with the
following primers: 50-ATGAAGCAGGACAGAAGGAACGGA and
30-GTCAGCTGCCCAACAACCTTCAAA for WT-1 (478 bp); 500-AT
CTCCAAGACCCCAGGTACACA and 30-AGGGTCAGGACGGCT
GAT for nephrin (182 bp); and 50-TCATGAGGTAGTCCGTCAGG
and 30-TCTAGGCACCAAGGTGTG for b-actin (460 bp).
Assessment of AKT, IR, IGF1-R, IRS-1, IjB, p-38, and PTEN
Cultured podocytes were treated with one of three different
concentrations of insulin (0.3, 3, or 30 nM) and incubated at 37 1C
for 20 min. Cells were collected in 150ml of lysis buffer and, after
determination of the protein concentration as above, phosphory-
lated and total AKT, IkB, and p-38 proteins were quantitatively
determined with the Bioplex platform as per manufacturer’s
recommendations (Bio-Rad). Glomerular and cortex lysates were
also obtained after homogenization and sonication and analysis of
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phosphorylated and total AKT performed. Data were calculated as
phosphorylated/total protein and expressed as percentage of
controls. Preliminary experiments where performed to check the
effect of recombinant IGF-1 (100 ng ml1; Biosource International,
Carlsbad, CA, USA) on AKT phosphorylation in both db/þ and
db/db podocytes. Results from initials experiments were confirmed
with the PhosphoPlus AKT activation kit (Cell Signaling, Danvers,
MA, USA) to validate the Bioplex platform. In addition, a
quantitative analysis of phosphorylated and total IRS-1, IGF-1
receptor (pYpY1135/1136), and IR b-subunit (Y1162/1163) was
obtained and expressed as U mg1 protein as per manufacturer’s
recommendations (AKT-Phospho and total 7-plex-kit; Invitrogen).
For assessment of phosphorylated and total PTEN, the same
lysates collected for Bioplex were analyzed by western blotting, as
described above, with mouse monoclonal antibodies anti-PTEN
(Cell Signaling).
Assessment of cell viability
Cultured podocytes were treated for 48 h as follows: (a) 10% FBS
media, (b) 0.1% FBS media, (c) 0.1% FBS media and TNF-a
(2000 U ml1; Roche, Florence, SC, USA), and (d) 0.1% FBS media,
TNF-a, and AKT inhibitor interfering with the function of
phosphorylated AKT (10 mM; Invitrogen). Podocytes were trypsi-
nized and stained with 7-amino-actinomycin-D (Invitrogen) and
FITC-labeled-zVAD-FMK (Promega, Madison, WI, USA), markers
for cell death and apoptosis, respectively. Analysis was performed by
flow cytometry and data expressed as percentages of controls.
Statistical analysis
In vitro assays were performed in duplicate or triplicate and were
repeated 4–6 times at different time points and at different passages
in culture. For in vivo experiments, results were obtained from six
mice per group. When comparing db/þ to db/db at baseline, an
unpaired t-test was used. When assessing the effect of different
stimuli in each group, a one-way analysis of variance was performed
and a Tukey’s correction for multiple comparisons was applied
(GraphPad-Prism; GraphPad Software Inc., San Diego, CA, USA).
Statistical significance was set at Po0.05.
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